CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Go back to CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Cytosorbents (CTSO) Tops Q4 EPS by 2c, Misses on Revenue

March 31, 2025 4:17 PM EDT

Cytosorbents (NASDAQ: CTSO) reported Q4 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $9.15 million versus the consensus estimate of $10.25 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

... More